biologit
Jean Redmond, PhD, currently serves as Chief Operating Officer and Head of Growth at biologit since September 2023. Prior experience includes a lengthy tenure at IQVIA from January 2015 to June 2023, where Jean held various leadership roles, including General Manager and Practice Leader for IQVIA MedTech Commercial Field Solutions, as well as Senior Director and Director of Strategic Planning in Real World Evidence. Earlier career experience includes a position as Analyst at Mansfield Advisors in 2014. Jean Redmond earned a PhD in Biological Sciences from the University of Cambridge (2010-2014) and a Bachelor's Degree in Clinical Nutrition from Trinity College Dublin (2005-2009).
This person is not in any teams
This person is not in any offices
biologit
Biologit delivers advanced active safety surveillance solutions for the life sciences sector, addressing human and veterinary pharmacovigilance, cosmetovigilance, nutravigilance, and materiovigilance. Biologit MLM-AI is a state-of-the-art platform for monitoring scientific literature to identify adverse events and emerging risks throughout a product's lifecycle, from clinical development to post-marketing. Designed for teams of all sizes, it combines a flexible workflow with a unified global and local scientific database, enhanced by unique AI-driven screening and productivity tools. These features enable fast, accurate, and fully traceable results for all safety surveillance needs. Biologit Database is a robust, continuously updated repository of scientific literature, optimised for compliant regulatory searches. It integrates global and regional sources into an intuitive interface, delivering high-quality results for monitoring adverse events and potential risks. With over 65 million entries and 40,000 new articles added daily from 120,000 journals across 170+ countries, it ensures comprehensive coverage aligned with FDA, EMA GVP and global standards. Biologit provides a full suite of pharmacovigilance services, including Qualified Person for Pharmacovigilance (QPPV) and Responsible Person for Pharmacovigilance (RPPV) support in clinical trials.